Granules Records Double-Digit Growth On The Back Of New Launches

As Company’s API Segment Grows By 12%

India’s Granules has grown through increased market penetration of its existing products as well as new product launches. The company is planning to invest in expanding its API capacity, finished dosages and a new multiple unit pellet facility.

profits
Granules reports quarterly and yearly growth across all segments and geographies • Source: Alamy

Granules India reported a 33% jump in sales in its financial fourth quarter ended 31 March 2021 and a 25% jump in the full-year figure to INR32.38bn ($442m), on the back of “new launches and an increase in the market share of existing products.”

Commenting on the full-year results, Krishna Chigurupati, chairman and managing director of Granules, said “multiple product launches across portfolios helped...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Products

More from Generics Bulletin